Stock screener

SION

Conviction 95HealthcareScan · Thu, Jun 25, 2026
Three white soldiers
SION$42.79+4.14%
ResistanceSupportVol 14Insider sell
63 bars
3
3
3
3
3
3
3
3
3
Vol MA14 472.4K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Sionna Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.sionnatx.com ↗
Price42.79
Change+4.14%
Gap-1.19%
Rel volume2.90×
Avg volume464.76K
Avg $ vol17.86M
SMA 2037.67
SMA 5039.93
SMA 20037.55
Price vs 50+7.17%
Price vs 200+13.96%
MA stackbullish
50/200 cross—
Supertrendup · 33.82
RSI (14)63
MACD hist0.84
MACD crossbull · 4d
Stoch %K / %D87 / 83
ADX (14)16
+DI / −DI31 / 16
RSI divergence—
MACD divergence—
ATR %+6.72%
ADR %7.36%
52w high45.95
52w low14.83
From 52w high-6.88%
Above 52w low+188.54%
New 52w highNo
SqueezeOff
Bollinger width31.81%
%B0.93
Donchian pos85.26%
Donchian high44.61
Donchian low32.26
AVWAP (52w high)39.62
vs AVWAP high+8.01%
AVWAP (52w low)35.38
vs AVWAP low+20.96%
OBV trendUp
Chaikin MF (20)-0.10
Today vs 20d2.90×
Avg vol (14d)472.4K
Avg vol (20d)464.76K
Avg $ vol (20d)17.86M
Market cap1.93B
RS 3m (vs SPY)+5.95%
RS 6m (vs SPY)-10.76%
RS line new highNo
Trend template8/8
Technical rank61.5
1 week+16.50%
1 month-0.21%
3 months+15.40%
6 months+0.87%
1 year+166.77%
YTD+9.13%
P/E-25.67
P/B6.70
P/S—
P/FCF-28.98
EPS-1.88
Div yield—
ROE-26.12%
ROA-24.67%
Debt/Eq—
Current22.60
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-22.01%
Price target51.71
Target upside20.85%
Analyst ratingBuy
Institutional103.70%
Ent. value1.87B
Revenue—
Net income-26.78M
Gross profit—
Free cash flow-66.67M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out45.15M
Employees59
ListedFri, Feb 7, 2025
Free float8.27M
Float %18.5%
Short interest4.64M
Days to cover14.5d
Short volume69.0%
Squeeze score99 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.60 vs −$0.52
Last surprise-15.4% miss
Setup gradeA+
Conviction95 / 100
Pattern quality—
Tech rank61.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree white soldiers
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SION

All disclosures →
No recent disclosed trades by Congress in SION. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SION · 9 buys · 1 sell

InsiderSideShares
Booth Bruce
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
Fleming Harold Edward
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
Clancy Paul J
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
RA CAPITAL MANAGEMENT, L.P.
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
Resnick Joshua
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
Ruddy Marcella K.
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
Thompson Peter A.
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
Stelzer Laurie
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
Viney Joanne L.
Director · Non-Qualified Stock Option (right to buy) · 2026-06-17
Grant17.34K
OrbiMed Capital GP VIII LLC
Director · Common Stock · 2026-05-27
Sell101

SEC filings

EDGAR filings in SION · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.